Q32 Bio Inc.
QTTB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $4 | $5 | $7 | $11 |
| G&A Expenses | $0 | $4 | $5 | $4 |
| SG&A Expenses | $4 | $4 | $5 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | $0 | $0 |
| Operating Expenses | $8 | $9 | $12 | $15 |
| Operating Income | -$8 | -$9 | -$12 | -$15 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | -$0 | $1 | $0 |
| Pre-Tax Income | -$7 | -$9 | -$11 | -$14 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$7 | -$9 | -$11 | -$14 |
| % Margin | – | – | – | – |
| EPS | -0.6 | -0.78 | -0.9 | -2.33 |
| % Growth | 23.1% | 13.3% | 61.4% | – |
| EPS Diluted | -0.6 | -0.78 | -0.9 | -1.16 |
| Weighted Avg Shares Out | 12 | 12 | 12 | 12 |
| Weighted Avg Shares Out Dil | 12 | 12 | 12 | 12 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $1 | $1 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$7 | -$9 | -$11 | $7 |
| % Margin | – | – | – | – |